Baglin A, Hanslik T, Vaillant J N, Boulard J C, Moulonguet-Doleris L, Prinseau J
Service de Médecine Interne et Néphrologie, Université René Descartes-Paris V, France.
Ann Med Interne (Paris). 1997;148(8):521-6.
A retrospective multicenter survey of the 230 chronic dialysis centers in metropolitan France, conducted between January 1 1998 and December 31 1992, to assess the incidence, causes and features of severe valvular heart disease among chronic dialysis patients, identified 98 patients. The annual incidence was estimated to be 15 to 19 cases per 10,000 dialysed patients. The most common etiologies were calcific valvular disease (69%) and endocarditis (19%). Calcific valvular disease led mostly to aortic stenosis, whereas endocarditis primarily caused mitral insufficiency. Two valves were damaged in 32% of the endocarditis patients versus 9% of those with calcific valvular disease. Sixty-one patients underwent surgery. Median overall survival after surgery was 25 +/- 3.0 months. Patients who underwent surgery for calcific valvulopathy, aortic stenosis or only aortic valve replacement had a median survival of 36 months. Patients who underwent surgery for endocarditis or replacement of 2 valves had a median survival of < 12 months. Actuarial survival of surgical patients differed significantly between: i) the patients for whom presurgical evaluation showed a single valvular lesion and those with multiple valvular lesions (p = 0.002), ii) the patients who had surgery to replace a single heart valve and those who had another type of surgery (p = 0.001), and iii) the patients who had surgery to insert a single aortic prosthetic heart valve and those who had another type of surgery (p = 0.004). Multivariate analysis (including etiologies, number of valvular lesions and type of surgery) showed that survival was significantly dependent only on the number of severe valvular lesions (p = 0.002). Five patients with severe calcific aortic stenosis died before scheduled surgery could be performed. These data suggest that, for patients on chronic dialysis, calcific aortic stenosis is the most frequent form of severe valvular disease. Because aortic stenosis progresses rapidly in these patients and thus quickly leads to irreversible cardiac failure, the operative risk, although high in this population, seems acceptable when only one valve is affected.
1992年1月1日至1998年12月31日期间,在法国大都市的230个慢性透析中心进行了一项回顾性多中心调查,以评估慢性透析患者中严重瓣膜性心脏病的发病率、病因和特征,共确定了98例患者。估计年发病率为每10000例透析患者中有15至19例。最常见的病因是钙化性瓣膜病(69%)和心内膜炎(19%)。钙化性瓣膜病主要导致主动脉瓣狭窄,而心内膜炎主要引起二尖瓣关闭不全。32%的心内膜炎患者有两个瓣膜受损,而钙化性瓣膜病患者这一比例为9%。61例患者接受了手术。术后总体生存中位数为25±3.0个月。因钙化性瓣膜病、主动脉瓣狭窄或仅行主动脉瓣置换术而接受手术的患者生存中位数为36个月。因心内膜炎或置换两个瓣膜而接受手术的患者生存中位数<12个月。手术患者的精算生存率在以下几组之间有显著差异:i)术前评估显示单一瓣膜病变的患者与有多个瓣膜病变的患者(p = 0.002),ii)接受单一心脏瓣膜置换手术的患者与接受其他类型手术的患者(p = 0.001),以及iii)接受单一主动脉人工心脏瓣膜植入手术的患者与接受其他类型手术的患者(p = 0.004)。多变量分析(包括病因、瓣膜病变数量和手术类型)显示,生存仅显著取决于严重瓣膜病变的数量(p = 0.002)。5例严重钙化性主动脉瓣狭窄患者在预定手术前死亡。这些数据表明,对于慢性透析患者,钙化性主动脉瓣狭窄是严重瓣膜病最常见的形式。由于主动脉瓣狭窄在这些患者中进展迅速,从而迅速导致不可逆的心力衰竭,尽管该人群手术风险很高,但当仅一个瓣膜受累时,手术风险似乎是可以接受的。